Accio Data, the background screening industry’s leading enterprise platform provider, and Intellicheck, Inc. (Nasdaq: IDN), an industry-leading identity company delivering on-demand digital and ...
Genmab Relies on IDBS’ ActivityBase XE for Analyzing Results from Its Discovery Activities Therapeutic monoclonal antibodies are the fastest growing segment within the pharmaceutical market. Among ...
MELVILLE, N.Y.--(BUSINESS WIRE)--Accio Data, the background screening industry’s leading enterprise platform provider, and Intellicheck, Inc. (Nasdaq: IDN), an industry-leading identity company ...